Verity & Verity, LLC Amgen Inc Transaction History

Verity & Verity, LLC

$875 Million
Q2 2024

A detailed history of Verity & Verity, LLC transactions in Amgen Inc stock. As of the latest transaction made, Verity & Verity, LLC holds 82,368 shares of AMGN stock, worth $26.4 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

82,368

Previous 85,022 3.12%

Holding current value

$26.4 Million

Previous $26.6 Million 3.12%

% of portfolio

2.94%

Previous 2.95%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 16, 2024	SELL	$262.75 - $319.31 $697,338 - $847,448	-2,654 Reduced 3.12%	82,368 $25.7 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $22.3 Million - $27.1 Million	85,022 New	85,022 $26.6 Million
Q1 2024 Sep 16, 2024	SELL	$268.87 - $324.56 $1.3 Million - $1.57 Million	-4,836 Reduced 5.69%	80,186 $22.8 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $52,929 - $59,711	207 Added 0.24%	85,900 $24.7 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $181,042 - $224,768	828 Added 0.98%	85,693 $23 Million
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $1.1 Million - $1.31 Million	5,151 Added 6.46%	84,865 $18.8 Million
Q1 2023 May 02, 2024	BUY	$225.79 - $275.2 $18 Million - $21.9 Million	79,714 New	79,714 $19.3 Million
Q1 2023 Apr 03, 2023	BUY	$225.79 - $275.2 $1.09 Million - $1.33 Million	4,816 Added 6.43%	79,714 $19.3 Million
Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $919,555 - $1.17 Million	4,015 Added 5.66%	74,898 $0
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $482,813 - $544,525	2,151 Added 3.13%	70,883 $16 Million
Q2 2022 Jun 30, 2022	BUY	$230.71 - $256.74 $174,416 - $194,095	756 Added 1.11%	68,732 $16.7 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $1.19 Million - $1.32 Million	5,447 Added 8.71%	67,976 $16.4 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $1.56 Million - $1.79 Million	7,862 Added 14.38%	62,529 $14.1 Million
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $786,248 - $921,184	3,704 Added 7.27%	54,667 $11.9 Million
Q2 2021 Sep 20, 2021	BUY	$233.58 - $259.14 $30,832 - $34,206	132 Added 0.26%	50,963 $12.4 Million
Q1 2021 Jun 21, 2021	BUY	$221.91 - $258.6 $1.85 Million - $2.16 Million	8,344 Added 19.64%	50,831 $12.1 Million
Q4 2020 Jan 12, 2021	BUY	$216.38 - $257.67 $1.88 Million - $2.24 Million	8,683 Added 25.69%	42,487 $10.1 Million
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $276,417 - $307,399	1,178 Added 3.61%	33,804 $8.65 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $1.8 Million - $2.2 Million	9,078 Added 38.55%	32,626 $8.16 Million
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $1 Million - $1.33 Million	-5,494 Reduced 18.92%	23,548 $4.77 Million
Q4 2019 Jan 08, 2020	BUY	$189.21 - $243.2 $61,493 - $79,040	325 Added 1.13%	29,042 $7 Million
Q3 2019 Oct 11, 2019	BUY	$174.11 - $208.62 $201,097 - $240,956	1,155 Added 4.19%	28,717 $5.65 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $618,123 - $724,580	3,708 Added 15.54%	27,562 $5.08 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $478,943 - $539,874	2,648 Added 12.49%	23,854 $4.53 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $431,549 - $503,756	2,419 Added 12.88%	21,206 $4.13 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $214,565 - $241,894	1,158 Added 6.57%	18,787 $3.89 Million
Q2 2018 Jul 20, 2018	SELL	$166.05 - $186.51 $78,873 - $88,592	-475 Reduced 2.62%	17,629 $3.01 Million
Q2 2018 Jul 20, 2018	BUY	$166.05 - $186.51 $78,873 - $88,592	475 Added 2.69%	18,104 $3.34 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $243,132 - $284,130	1,435 Added 8.86%	17,629 $3.01 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $267,532 - $298,915	1,585 Added 10.85%	16,194 $2.82 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $2.44 Million - $2.79 Million	14,609	14,609 $2.72 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.

Account

Verity & Verity, LLC Amgen Inc Transaction History